Amwise Diagnostic Company
Amwise Diagnostic is a leader in precision medicine technology for cancer. Our patented genetic analysis technologies assist doctors and patients in determining the most appropriate individualized treatment strategy that has optimal treatment effectiveness and minimal treatment-related adverse events.
%20.jpg)
%20.jpg)
Headquarters:
Taipei, T'ai-pei, Taiwan
Last Funding Date:
2020-02-26
Funding Status:
Early Stage Venture
Investors Number:
4
Founded Date:
2015-01-01
Last Funding Type:
Series B
Employee Number:
11-50
Total Funding:
$10M
Industry:
Biotechnology, Health Care, Life Science
Estimated Revenue:
$1M to $10M
Technology:
diagnostics